Jula Inrig Net Worth & Insider Trades
Jula Inrig - Chief Medical Officer, Travere Therapeutics, Inc
What is Jula Inrig's Net Worth?
The current estimated net worth of Travere Therapeutics, Inc's Chief Medical Officer, Jula Inrig, is estimated to be about $475.93K . Jula Inrig owns about 17,507 units of Travere Therapeutics, Inc common stock. In the last year at Travere Therapeutics, Inc, Jula Inrig has sold an estimated value of $51.73K worth.
What is Jula Inrig's Past Insider Trading?
Jula Inrig's largest sale order was 2,493 units , worth over $51.73K on January 6, 2023. In total, Jula Inrig has made about 4 transactions over a year of their time at Travere Therapeutics, Inc. Jula Inrig usually trades in February and January, with the busiest year in 2022 and 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Jula Inrig
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Jula Inrig's' Mailing Address?
- Mailing address is C/o Travere Therapeutics, Inc. 3611 Valley Centre Drive, Suite 300 San Diego CA 92130 CA
Travere Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Eric Dube, Ph.D. | 2020 | $660,938 | - | $457,125 | $1,546,000 | $2,772,090 | $11,726 | $5,447,879 |
| Eric Dube, Ph.D. | 2019 | $618,188 | $100,000 | $337,500 | $2,441,760 | $5,977,280 | $204,591 | $9,679,319 |
| Laura Clague | 2020 | $436,801 | - | $254,239 | $432,880 | $508,217 | $16,577 | $1,648,714 |
| Laura Clague | 2019 | $419,271 | - | $200,747 | $215,520 | $453,000 | $15,044 | $1,303,582 |
| Laura Clague | 2018 | $399,583 | - | $185,150 | $497,803 | $769,522 | $8,250 | $1,860,308 |
| Elizabeth Reed | 2020 | $413,417 | - | $235,463 | $432,880 | $508,217 | $11,214 | $1,601,191 |
| Elizabeth Reed | 2019 | $391,667 | - | $187,500 | $215,520 | $453,000 | $10,760 | $1,258,447 |
| Elizabeth Reed | 2018 | $347,500 | - | $161,000 | $391,180 | $673,331 | $8,250 | $1,581,261 |
| Noah Rosenberg, M.D. | 2020 | $447,002 | - | $254,573 | $432,880 | $508,217 | $12,360 | $1,655,032 |
| Noah Rosenberg, M.D. | 2019 | $432,083 | - | $195,075 | $215,520 | $453,000 | $73,965 | $1,369,643 |
| Noah Rosenberg, M.D. | 2018 | $183,622 | $100,000 | $97,750 | $571,600 | $1,183,611 | $266,500 | $2,403,083 |
| William E. Rote, Ph.D. | 2020 | $447,474 | - | $254,800 | $432,880 | $508,217 | $14,303 | $1,657,674 |
| William E. Rote, Ph.D. | 2019 | $432,858 | - | $195,736 | $215,520 | $453,000 | $13,112 | $1,310,226 |
| William E. Rote, Ph.D. | 2018 | $420,250 | - | $194,258 | $370,531 | $625,236 | $8,250 | $1,618,525 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1438533/000143853321000012/tvtx-2021definitiveproxy.htm
What are Travere Therapeutics, Inc's Past Insider Trades?
Travere Therapeutics, Inc's most recent insider trade came on September 5, 2023 by Christopher Cline who sold 457 units worth $6.72K . In the last 3 years, insiders at Travere Therapeutics, Inc have sold an estimated value of $10.99M and bought an estimated value of $1.71M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Elizabeth E Reed, SVP, Eric Dube, Chief Executive Officer, and William Rote, Senior Vice President .
Travere Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||